CFRA Maintains Strong Buy Recommendation On Shares Of Asml Holding N.v.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target by $118 to $849, 29.5x our ’25 EPS view, near ASML’s three-year average two-year forward multiple (~29.4x), as we shift our focus from ’24 to ’25. We lower our ’24 EPS estimate to EUR19.65 from EUR19.88 and increase ’25’s view to EUR26.15 from EUR25.56 as we budget in a bit more softness in early ’24, followed by an acceleration toward the end of the year and solid strength in ’25 as new technologies like gate-all-around are introduced in higher volumes. We see Chinese demand pulling back to start ’24 as export restrictions take hold, but we expect demand for ASML’s one-of-a-kind systems to be picked up by other countries as the global race for advanced semiconductor technology continues. We note ASML’s backlog remains sizable (EUR35B), supporting sales despite a soft macro. We do not expect much competition from Canon’s nanoimprint lithography machines (which recently achieved 5-nm production capability) given the advantage in volume and reliability offered by ASML’s EUV machines.

Scroll to Top